Microbiology Testing Market Outlook:
Microbiology Testing Market size was over USD 6.2 billion in 2024 and is estimated to reach USD 12.8 billion by the end of 2034, exhibiting a CAGR of 8.1% during the forecast period, i.e., 2025-2034. In 2025, the industry size of the microbiology testing is estimated at USD 6.6 billion.
The rising infectious diseases and antimicrobial resistance (AMR) incidences are creating a notable surge in the market. According to a report from the World Health Organization (WHO), these medical conditions resulted in 1.5 million deaths every year till 2024, which is further expected to surpass 10.3 million by 2050 in the absence of adequate intervention. Particularly, the occurrence of associated illnesses, such as TB and sepsis, is evidently higher in Sub-Saharan Africa and South Asia, where resources are limited. This underscores the critical role of microbial quality control in combating contamination issues and improving public health outcomes.
Despite the growing demand, the market supply chain volatilities are still impacting its overall performance. For instance, in 2023, shortages in resin drove a 12.4% year-over-year (YoY) increase in the producer price index (PPI) for plastic-based labware, as unveiled by the U.S. Bureau of Labor Statistics (BLS). Subsequently, these upstream inflations translated to a 7.1% rise in the consumer price index (CPI) for clinical laboratory services. To overcome the disparity, in 2023, manufacturers are increasingly adopting automated PCR system assembly lines, which helped them with a 15.6% reduction in manufacturing lead times, as per the OECD Science & Technology Report.
